We are live on
!
Find out more
OASM
Oasmia Pharmaceutical AB
OASM
OASM
Delisted
OASM was delisted on the 21st of August, 2019.
8 hedge funds and large institutions have $187K invested in Oasmia Pharmaceutical AB in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
60% more funds holding
Funds holding: 5 → 8 (+3)
42% less capital invested
Capital invested by funds: $323K → $187K (-$136K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$60.2K |
| 2 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$28.6K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$480 |
Top Sellers
| 1 |
Jane Street
New York
|
-$123K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$23.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.14K |
| 4 |
Morgan Stanley
New York
|
-$3 |